Data completeness
1/8 — Limited
TEGOPEN (cloxacillin sodium) by Bristol Myers Squibb is action: cloxacillin benzathine is bactericidal in action against susceptible organisms during the stage of active multiplication.
Drug data last refreshed 4h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TEGOPEN (cloxacillin sodium) is an oral penicillinase-resistant penicillin antibiotic in solution form, developed by Bristol Myers Squibb. It is bactericidal, inhibiting bacterial cell wall biosynthesis and is active against gram-positive organisms including penicillin G-resistant Staphylococcus aureus. The product is indicated for treatment of infections caused by susceptible organisms, particularly those resistant to standard penicillins.
Pre-Launch
Pre-launch stage indicates early-stage commercial planning with limited team infrastructure; significant opportunity for founding brand and commercial strategy roles.
Mechanism of Action
ACTION: Cloxacillin benzathine is bactericidal in action against susceptible organisms during the stage of active multiplication. It acts through the inhibition of biosynthesis of cell wall mucopeptide. It is active against gram-positive organisms associated with mastitis such as Staphylococcus…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on TEGOPEN offers a rare opportunity to build a commercial franchise from pre-launch stage within Bristol Myers Squibb's established infrastructure. Roles will focus on regulatory approval strategy, market access planning, competitive positioning, and launch execution in the oral antibiotic space.
Brand Manager
Worked on TEGOPEN at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.